Brokerages Set Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Target Price at $53.50
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has received an average rating of “Buy” from the nine ratings firms that are covering the stock, MarketBeat reports. Eight equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average twelve-month price […]
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has received an average rating of “Buy” from the nine ratings firms that are covering the stock, MarketBeat reports. Eight equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average twelve-month price […]
